The majority of Aspergillus-induced infections in man are caused by the pat
hogenic fungus A. fumigatus, which secretes biologically and immunologicall
y active glycosylated and nonglycosylated proteins. The complexity in the a
ntigenic structure of A. fumigatus and the varying host immune responses le
ad to a wide spectrum of clinical conditions such as allergic bronchopulmon
ary aspergillosis (ABPA), aspergilloma, and invasive aspergillosis. It is r
eported that 15-20% of allergic asthmatics suffer from Aspergillus-induced
allergies. The incidence of opportunistic infections, including Aspergillus
infections, has risen because of the increase in the incidence of HIV and
tuberculosis. Allergic bronchopulmonary aspergillosis is an immunologically
significant clinical form where type I and type III hypersensitivity react
ions are involved in pathogenesis. High levels of specific IgE and IgG anti
bodies in these patients are of diagnostic value. Molecular characterizatio
n of certain immunodominant allergens and antigens of A. fumigatus revealed
the presence of complex carbohydrate moieties, heat-shock proteins, enzyme
activities such as elastase, protease, catalase, dismutase, and cytotoxic
ribonuclease. A Con A binding allergen / antigen (45 kDa) and Con A nonbind
ing allergen/antigen (18 kDa, Asp fI) have a multifunctional nature. The mu
ltifunctional nature of these antigens may play an important role in the pa
thogenesis of the disease. Significant amounts of a major allergen/antigen
of molecular weight 18 kDa is excreted in large amounts through the urine o
f patients with invasive aspergillosis. Studies on the structure-function r
elationship of the 18-kDa allergen/antigen revealed the involvement of tryp
tophan residues in binding with monoclonal antibodies (MAbs). Also, the his
tidine residues and cysteine disulfide bonds of the 18-kDa allergen are inv
olved in its catalytic activity. The high load of multifunctional antigens
in the serum of patients for prolonged periods, the presence of high levels
of specific antibodies, and the absence of protective antibodies in ABPA p
atients have necessitated studies on the functional properties of the antib
odies. The present study shows significant immunoreactivity of antibodies i
n patients of ABPA to fibronectin and collagen. Analysis of IgG antibodies
from the patients of ABPA showed the presence of DNA-cleaving activity. The
se observations offer a new line of thinking in understanding the mechanism
of pathogenesis of Aspergillus-induced clinical manifestations, and may le
ad to novel approaches to intervention in the inflammation and infection ca
used by fungal pathogens.